Mark T Frost insider trades

Open-market stock purchases and sales by Mark T Frost, Chief Financial Officer at Harvard Bioscience Inc, from SEC Form 4 filings since Mar 8, 2010.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +24%.

Recent trades

DateStockTradeValue
Mar 20, 2026HBIO Harvard Bioscience IncBought (not open market)—
Mar 16, 2026HBIO Harvard Bioscience IncBought$25K

Companies traded

  • HBIO Harvard Bioscience Inc: 1 buy, last Mar 20, 2026
  • FATH Fathom Digital Manufacturing Corp: 1 sale, last Apr 4, 2024
  • ALOG Analogic Corp: other filings, last Dec 5, 2016
  • ANGO Angiodynamics Inc: other filings, last Aug 6, 2015
  • AMRI Albany Molecular Research Inc: 1 buy, last Sep 14, 2012

Get free alerts when Mark T Frost files a new trade →